• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD EXTENSION SET FLOW CONTROLLER; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD EXTENSION SET FLOW CONTROLLER; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number RG-1
Device Problem Excess Flow or Over-Infusion (1311)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/19/2023
Event Type  malfunction  
Manufacturer Narrative
Medical device lot #: ta210373 was reported, however, this is not a lot # manufactured for the reported catalog #.Medical device expiration date: unknown.Device manufacture date: unknown.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported while using bd flow controller over infusion occurred.There was no report of patient impact.The following information was provided by the initial reporter: the substance does not regulate the passage of the solution properly.The solution runs out before the end of the scheduled time, as it was tested with 500 ml at 250 ml / h, and the solution ran out within an hour and a half instead of two hours.
 
Manufacturer Narrative
H6: investigation summary: a rg-1 product was not available for investigation; however the customer confirmed that the complaint sample was from lot ta210373.The customer indicates that the infusion was completed in one and a half hours instead of the expected two hours.The details of this feedback were forwarded to the manufacturing site for investigation.A review of the production records for lot ta210373 did not identify any in-process testing failures or quality deviations which may have resulted in a report of this nature.During previous testing it has been confirmed that the rate indicated on the graduated scale of the tutodrop component may differ from the rate being set by the customer.As stated in the directions for use box insert ¿warnings: the i.V.Fluid container must be suspended approximately 80cm above the patient¿s mid-auxiliary line.The graduated scale is indicative and serves as a guide.The flow rate must be verified by counting drops and the flow controller adjusted until the correct rate is obtained.Avoid setting the flow controller too close to the open position since the flow rate could increase sharply¿.It is important that these instructions are adhered to in order to achieve optimum performance.The scale on the tutodrop should not be used alone to set the rate of the device.During previous testing of tutodrop products it has been confirmed that when the infusion rate is set by counting the number of drops per minute, the rate accuracy does not significantly drift over time.Please note that the tutodrop is designed for use with gravity infusions.The tutodrop allows a more consistent flow than a standard roller clamp as flow rate drift is improved when compared to a standard roller clamp.As with all gravity infusions, it is important that the flow rate is checked by counting the drops during set-up and at regular intervals after this.As with all gravity infusions the flow rate will be influenced by multiple factors including: the head-height of the bag, changes in the bag head-height during an infusion, the size of the cannula, positioning of the cannula, type/viscosity of the fluid, size and condition of the vein, fluid temperature, etc.A high degree of accuracy is not guaranteed when infusing by gravity.If a high degree of flow rate accuracy is required, the user should consider a flow-controlling infusion pump.
 
Event Description
It was reported while using bd flow controller over infusion occurred.There was no report of patient impact.The following information was provided by the initial reporter: the substance does not regulate the passage of the solution properly.The solution runs out before the end of the scheduled time, as it was tested with 500 ml at 250 ml / h, and the solution ran out within an hour and a half instead of two hours.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD EXTENSION SET FLOW CONTROLLER
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key16531180
MDR Text Key311581325
Report Number9616066-2023-00432
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeJO
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue NumberRG-1
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-